NRx Pharmaceuticals Inc Market Cap ($129.52)
Market Cap & Net Worth: NRx Pharmaceuticals Inc (NRXPW)
NRx Pharmaceuticals Inc market cap. NRx Pharmaceuticals Inc (NASDAQ:NRXPW) has a market capitalization of $129.52 ($129.52) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #32065 globally and #6480 in its home market, demonstrating a 91.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NRx Pharmaceuticals Inc's stock price $0.01 by its total outstanding shares 9121 (9.12K). Also see cash efficiency ratio of NRx Pharmaceuticals Inc for how efficiently the company converts equity into cash flow.
NRx Pharmaceuticals Inc Market Cap History (2017–2026)
NRx Pharmaceuticals Inc market cap history from 2017 to 2026. Data shows change from $3.65K to $129.52 (-31.48% CAGR). Check NRXPW live share price for real-time trading data and today's change.
NRx Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NRx Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of NRx Pharmaceuticals Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
NRx Pharmaceuticals Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $3.51K | $1.09 Million | $66.10K | 0.00x | 0.05x |
| 2019 | $1.58K | $1.21 Million | $408.43K | 0.00x | 0.00x |
| 2025 | $645.77 | $1.23 Million | -$28.62 Million | 0.00x | N/A |
Competitor Companies of NRXPW by Market Capitalization
Companies near NRx Pharmaceuticals Inc in the global market cap rankings as of November 4, 2026. Also see NRx Pharmaceuticals Inc (NRXPW) total assets for a full breakdown of the balance sheet.
Key companies related to NRx Pharmaceuticals Inc by market ranking:
- Carbon Revolution Public Limited Ordinary Shares (NASDAQ:CREV): Ranked #32056 globally with a market cap of $192.78 USD.
- Shineco Inc (NASDAQ:SISI): Ranked #32057 globally with a market cap of $180.12 USD.
- CuriosityStream Inc (NASDAQ:CURIW): Ranked #32066 globally with a market cap of $116.21 USD.
- Versus Systems Inc (NASDAQ:VSSYW): Ranked #32067 globally with a market cap of $115.40 USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #32056 | Carbon Revolution Public Limited Ordinary Shares | NASDAQ:CREV | $192.78 | $0.00 |
| #32057 | Shineco Inc | NASDAQ:SISI | $180.12 | $0.00 |
| #32066 | CuriosityStream Inc | NASDAQ:CURIW | $116.21 | $0.01 |
| #32067 | Versus Systems Inc | NASDAQ:VSSYW | $115.40 | $0.01 |
Market Capitalization of NRx Pharmaceuticals Inc (2017–2026)
Market capitalization of NRx Pharmaceuticals Inc from 2017 to today. Between 2017 and today, NRx Pharmaceuticals Inc's market cap moved from $3.65K to $ 129.52, with a yearly change of -31.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $129.52 | -79.94% |
| 2025 | $645.77 | -44.69% |
| 2024 | $1.17K | -1.31% |
| 2023 | $1.18K | -48.14% |
| 2022 | $2.28K | -86.48% |
| 2021 | $16.87K | -60.64% |
| 2020 | $42.87K | +2608.93% |
| 2019 | $1.58K | -54.85% |
| 2018 | $3.51K | -3.92% |
| 2017 | $3.65K | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of NRx Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $129.52 USD |
| MoneyControl | $129.52 USD |
| MarketWatch | $129.52 USD |
| marketcap.company | $129.52 USD |
| Reuters | $129.52 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NRx Pharmaceuticals Inc
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone… Read more